2013 Gold Medal Tribute  by unknown
Volume 87  Number 2S  Supplement 2013 A292013 Gold Medal TributeAmato J. Giaccia, PhD
Tribute by Quynh-Thu Le, MD, and Albert C. Koong, MD, PhD
It is a great honor for us to pay tribute to one of this year’s ASTRO Gold Medal recipients, Amato J. Giaccia, PhD,
who is one of the most accomplished radiation biologists and highly respected educators in our field.
Amato obtained his undergraduate degree at Lafayette College in Easton, PA, and his PhD in pathology/molecular
biology from the University of Pennsylvania in Philadelphia. He joined Stanford University in Stanford, CA, in 1989
as a postdoctoral fellow in the laboratory of J. Martin Brown, PhD, FASTRO. In 1992, Amato was appointed to the
faculty in the department of radiation oncology at Stanford. Since then, he has received continuous research funding
from the National Cancer Institute (NCI) and was a recipient of a National Institutes of Health Merit award. This
award provides long-term support to ‘‘investigators with impressive records of scientific achievement in research
areas of special importance or promise’’ and is bestowed upon fewer than 5% of NIH-funded investigators.
Amato’s laboratory has made significant advances to the field of cancer biology, particularly in understanding the role
of the tumor microenvironment in tumor progression and metastasis. Although hypoxia has been long implicated in
the malignant progression of solid tumors, Amato was the first scientist to provide a mechanistic explanation for this
observation. In a seminal paper, he showed that hypoxia selects cells with diminished apoptotic potential, specifically
those with p53 mutations, thereby exerting a selective pressure for tumor cells with increased malignant potential.
This study established the molecular basis for hypoxia-mediated tumor aggressiveness and profoundly impacted
research in the entire field.
Another fundamental concept demonstrated by Amato was the idea that tumor cell invasion and metastasis are
mediated by secreted proteins, induced by tumor-microenvironmental stresses. He identified Connective Tissue
Growth Factor (CTGF), Lysyl Oxidase (LOX), and AXL as secreted proteins that are essential for hypoxia-induced
tumor progression and metastasis. These proteins have since become the focus of active clinical/translational
investigation in multiple laboratories and biotechnology companies. More importantly, Amato has advanced his
laboratory findings into multiple clinical studies by developing protein-targeting strategies.
In addition to advancing cancer research, Amato is highly dedicated to fostering the growth of trainees in radiation
oncology. More than 20 of his former trainees now hold academic appointments as independent investigators in
research institutions throughout the world. These scientists have helped train the next generation of researchers.
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collaboration with Eric J. Hall, DSc, DPhil, FASTRO, he co-authored the last two editions of the seminal textbook
Radiobiology for the Radiologist, which is used globally for training radiology and radiation oncology residents. As
the chair of the American Board of Radiology’s (ABR) Radiation Biology Committee, he has continued to update the
radiation biology section of the written ABR certification exam. He also chaired the NCI Radiation Research Study
Section for several years. He has continuously served on the Radiation and Cancer Biology Committee of ASTRO
since 1994 and is a major contributor to the Education Committee. He also serves on the editorial boards of multiple
radiation oncology and radiation biology journals.
We believe that, in addition to his distinguished research, his mentorship of junior members in the field and his service
to the radiation oncology community as a whole are perhaps his most enduring contributions. Our field is renewed and
advanced by attracting outstanding young scientists to build upon the work of our predecessors.
Amato’s numerous contributions transcend the field of radiobiology and have a far-reaching impact for the entire
community of basic scientists and clinical oncologists. We cannot think of any other scientist who is more deserving
of the ASTRO Gold Medal than Amato Giaccia.
